Prognostic value of neutrophil-to-lymphocyte ratio combined with platelet-to-lymphocyte ratio, serum creatinine and NT-proBNP in HFpEF patients with qi deficiency and blood stasis syndrome
This study demonstrates that the neutrophil-to-lymphocyte ratio (NLR) is an independent prognostic indicator for major adverse cardiovascular events in patients with heart failure with preserved ejection fraction and qi deficiency and blood stasis syndrome, and that a combined model incorporating NLR, platelet-to-lymphocyte ratio, serum creatinine, and NT-proBNP offers superior predictive accuracy for identifying high-risk patients.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine your body as a bustling, high-tech city. In this city, the heart is the central power plant, pumping energy to every neighborhood. Sometimes, even when the plant's main engine is still running strong (pumping out a normal amount of blood), the pipes get clogged or stiff, causing traffic jams and backups. This is a condition doctors call Heart Failure with Preserved Ejection Fraction, or HFpEF for short. It's tricky because the engine looks fine on paper, but the city is still in trouble.
To figure out how bad the trouble is, doctors usually look at specific "smoke signals" in the blood. One famous signal is a molecule called NT-proBNP, which is like a siren screaming that the heart is under stress. Another is creatinine, a marker that tells us if the kidneys (the city's water filtration system) are working. But scientists are always hunting for new, sharper signals. Recently, they've been looking at the ratio of different types of white blood cells—specifically, the "soldiers" (neutrophils) versus the "peacekeepers" (lymphocytes). Think of this as checking if the city is in a state of constant, low-level war (inflammation) that might be damaging the pipes over time. The big question is: Can we combine these different signals to predict which patients might have a major emergency, like a heart attack or a return to the hospital, sooner than others?
This study, conducted by researchers at Dongzhimen Hospital, decided to test a new "super-signal" strategy. They focused on 154 patients who had HFpEF and also fit a specific description in Traditional Chinese Medicine (TCM) known as "qi deficiency and blood stasis." In plain English, this TCM view sees the problem as a lack of vital energy (qi) that fails to push blood through the vessels, leading to sluggish flow and "stasis" (clumping). The researchers wanted to see if combining the blood cell ratios (NLR and PLR) with the kidney marker (creatinine) and the heart stress marker (NT-proBNP) could predict who would suffer a Major Adverse Cardiovascular Event (MACE) within one year.
The team followed these patients for a year, checking to see who ended up in the "MACE group" (those who died from heart issues, had to be readmitted for heart failure, or suffered a heart attack) and who stayed in the "non-MACE group." They found that 51 out of the 154 patients (about 33.1%) did experience these bad events. When they compared the two groups, the patients who had the bad events had higher levels of the "soldier" cells compared to the "peacekeepers" (a high Neutrophil-to-Lymphocyte Ratio, or NLR), higher platelet ratios, higher creatinine, and higher NT-proBNP.
However, when they ran the numbers to see which signal was the true boss, the NLR stood out. It was the only one that remained a strong, independent predictor even when all the other factors were considered together. The researchers calculated that for every step up in the NLR score, the risk of a bad event went up significantly. While the other markers (like PLR, creatinine, and NT-proBNP) were higher in the sick group, they didn't hold up as strong independent predictors when tested alone in the complex math model.
But here is the most exciting part: the researchers built a "combined model." They took the NLR, the platelet ratio, the creatinine, and the NT-proBNP and mashed them all into one prediction tool. This team effort worked better than any single signal could on its own. The combined model had a "score" (called an AUC) of 0.799, which suggests it is quite good at telling the difference between patients who will have an event and those who won't. At its best setting, this model could correctly identify about 72% of the patients who would have an event while correctly ruling out about 88% of those who wouldn't.
The study suggests that for patients with HFpEF who also have the "qi deficiency and blood stasis" pattern, keeping an eye on the balance of their white blood cells (the NLR) is crucial. Furthermore, using a combination of heart, kidney, and inflammation markers might help doctors spot high-risk patients earlier. This could allow for more personalized care, blending modern Western medicine with TCM principles to keep the city's power plant running smoothly for longer. The authors note, however, that this was a single-center study with a limited number of people, so while the results are promising, they need to be tested in larger groups to be sure.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.